English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Eli Lilly And Company
Patient Daily
| May 25, 2023
Lilly ESG Report Highlights Progress Towards Sustainability Goals
Patient Daily
| May 24, 2023
Lilly's peresolimab Phase 2a rheumatoid arthritis trial published in The New England Journal of Medicine
Patient Daily
| May 22, 2023
Loxo@Lilly Announces Details of Presentations at 2023 European Hematology Association (EHA) Annual Meeting
Patient Daily
| May 9, 2023
Lilly Provides $500,000 in Grants to Support Equitable Access to Education for Dreamers in Indiana
Patient Daily
| May 9, 2023
Lilly Declares Second-Quarter 2023 Dividend
Patient Daily
| May 9, 2023
Lilly's tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes in SURMOUNT-2
Patient Daily
| Apr 26, 2023
Lilly to Divest BAQSIMI to Amphastar
Patient Daily
| Apr 26, 2023
Lilly to Make Record-Breaking Investment in Indiana Manufacturing Facilities
Trending
+
Community
Patient Daily
| Mar 27, 2025
Healthcare professionals recognized at National Breathe Free conference for outstanding dedication
+
Regulatory
Patient Daily News Service
| Mar 28, 2025
Former HHS Official: '340B program is just one of many reminders of the abuse and waste' in D.C.
+
Pharmaceuticals
Patient Daily
| Mar 31, 2025
Founder of RXSaveCard on drug pricing: 'We typically see savings of $6,000+ per prescription'
+
Pharmaceuticals
Patient Daily
| Apr 1, 2025
American Lung Association responds to HHS budget cuts
1
2
3
»
Last »